Cagoco, Nenia .
HRN: 25-80-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2024
CEFUROXIME 500MG (TAB)
09/25/2024
10/02/2024
PO
500mg
BID
S/P NSVD, Thinly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes